TOKYO -- Japan will ease regulations on clinical trials for new drugs developed overseas, Nikkei has learned, scrapping the rule that in principle drugs' safety must be tested on Japanese before they can be launched in the domestic market.
Pharmaceuticals
Japan to scrap rule requiring testing of new drugs on Japanese
Dropping slow process in early clinical trials would make medicines available sooner
About 70% of new drugs approved in Europe and the U.S. do not win approval for use in Japan.
Read Next
Latest on Pharmaceuticals
